Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology

被引：93

作者：

Schmidt, Morten ^{[1
]}

Lamberts, Morten ^{[2
]}

Olsen, Anne-Marie Schjerning ^{[2
]}

Fosboll, Emil ^{[3
]}

Niessner, Alexander ^{[4
]}

Tamargo, Juan ^{[5
]}

Rosano, Giuseppe ^{[6
,7
]}

Agewall, Stefan ^{[8
,9
]}

Kaski, Juan Carlos ^{[10
]}

Kjeldsen, Keld ^{[11
,12
,13
]}

Lewis, Basil S. ^{[14
]}

Torp-Pedersen, Christian ^{[15
]}

机构：

[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Olof Palmes Alle 43-45, DK-8200 Aarhus, Denmark

[2] Copenhagen Univ Hosp, Dept Cardiol, Hellerup, Denmark

[3] Rigshosp, Copenhagen Univ Hosp, Ctr Heart, Dept Cardiol, DK-2100 Copenhagen, Denmark

[4] Med Univ Vienna, Div Cardiol, Dept Internal Med 2, Vienna, Austria

[5] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain

[6] IRCCS San Raffaele Roma, Rome, Italy

[7] St George Hosp, Cardiovasc & Cell Sci Inst, London, England

[8] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway

[9] Univ Oslo, Inst Clin Med, Oslo, Norway

[10] Univ London, St Georges, Div Cardiac & Vasc Sci, London, England

[11] Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark

[12] Holbaek Cent Hosp, Holbaek, Denmark

[13] Aalborg Univ, Fac Med, Aalborg, Denmark

[14] Technion Israel Inst Technol, Lady Davis Carmel Med Ctr, Ruth & Bruce Rappaport Sch Med, Tel Aviv, Israel

[15] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark

来源：

EUROPEAN HEART JOURNAL | 2016年 / 37卷 / 13期

关键词：

RECEIVING ANTITHROMBOTIC THERAPY; CYCLOOXYGENASE-2; INHIBITORS; MYOCARDIAL-INFARCTION; GASTROINTESTINAL TOXICITY; SELECTIVE INHIBITORS; ATRIAL-FIBRILLATION; DOUBLE-BLIND; RISK; EVENTS; METAANALYSIS;

D O I：

10.1093/eurheartj/ehv505

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1015 / U26

页数：11

共 50 条

[21] Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines
Pham, Timothy T.
Miller, Michael J.
Harrison, Donald L.
Lloyd, Ann E.
Crosby, Kimberly M.
Johnson, Jeremy L.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2013, 19 (06) : 1026 - 1034
[22] Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
McGettigan, Patricia
Henry, David
PLOS MEDICINE, 2011, 8 (09)
[23] Non-aspirin non-steroidal anti-inflammatory drugs in prevention of colorectal cancer in people aged 40 or older: A systematic review and meta-analysis
Tomic, Tanja
Dominguez-Lopez, Santiago
Barrios-Rodriguez, Rocio
CANCER EPIDEMIOLOGY, 2019, 58 : 52 - 62
[24] Non-steroidal anti-inflammatory drugs and the heart
Aneja, Ashish
Farkouh, Michael E.
HEART, 2011, 97 (07) : 517 - 518
[25] Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer
Lim, Wei-Yen
Chuah, Khoon Leong
Eng, Philip
Leong, Swan Swan
Lim, Elaine
Lim, Tow Keang
Ng, Alan
Poh, Wee Teng
Tee, Augustine
Teh, Ming
Salim, Agus
Seow, Adeline
LUNG CANCER, 2012, 77 (02) : 246 - 251
[26] Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications
Bello, Alfonso E.
Holt, Robert J.
DRUG SAFETY, 2014, 37 (11) : 897 - 902
[27] Pharmacoepidemiology of non-steroidal anti-inflammatory drugs
Moore, Nicholas
Duong, Mai
Gulmez, Sinem Ezgi
Blin, Patrick
Droz, Cecile
THERAPIE, 2019, 74 (02): : 271 - 277
[28] Use of Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Relation to Cardiovascular Events. A Systematic Pharmacoepidemiological Review
Kontogiorgis, Christos
Valikeserlis, Ioannis
Hadjipavlou-Litina, Dimitra
Nena, Evangelia
Constantinidis, Theodoros C.
CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (06) : 502 - 513
[29] Appropriate prescription, adherence and safety of non-steroidal anti-inflammatory drugs
Sostres, Carlos
Lanas, Angel
MEDICINA CLINICA, 2016, 146 (06): : 267 - 272
[30] Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs
Stehlik, Paulina
Rosella, Laura
Henry, David
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) : 362 - 367

← 1 2 3 4 5 →